Mindset Pharma Inc. has announced that it has entered into a pharmaceutical manufacturing agreement with a leading contract development and manufacturing organization (CDMO), for the production of pharmaceutical-grade batches of Mindset’s next-generation psilocybin drug candidate, MSP-1014.
Category Press Release
Published in Yahoo Finance